Booster doses not recommended for people aged 12–15 years
On 8 April 2022 the TGA approved a booster dose of Comirnaty (Pfizer) COVID-19 vaccine for use in adolescents aged 12-15 years. However at this time, ATAGI does not recommend that adolescents aged 12-15 years need to receive a booster dose of Pfizer COVID-19 vaccine. Current data suggest that COVID-related serious illness is very rare in adolescents aged 12-15, particularly after completion of a primary series of COVID-19 vaccination. ATAGI will continue to review and consider new evidence on the benefits and risks of any additional doses in 12-15 year olds, including for those with underlying medical conditions.
COVID-19 Program site or vaccine withdrawals
Practices can choose to withdraw from the COVID-19 Program completely or withdraw from administering selected vaccines. Contact CESPHN at email@example.com to notify your intention to withdraw or amend the vaccines you will be administering. CESPHN will pass this information onto the Taskforce in a timely manner to enable the accurate administration of the request.
COVID-19 incentive and MBS item extension
COVID-19 MBS items and COVID-19 practice incentives have been extended to 31 December 2022:
MBS item 93624 – First dose suitability assessment
Novavax COVID-19 vaccine real-time safety data is now available. People in Australia are reporting similar rates of expected short-term vaccine side effects following Novavax COVID-19 vaccine as those reported by people who received other COVID-19 vaccines.
The process of administering a vaccine may cause severe anxiety in some individuals with needle-phobia and may be difficult in certain individuals with behavioural disorders. In patients where non-pharmacological techniques have failed, sedation may facilitate safe administration of vaccines in some special circumstances.
In-language videos about COVID-19 vaccination
In-language videos with multicultural GPs about vaccinating children aged 5 to 11 is now available in Assyrian, Cantonese, Mandarin, Hindi and Punjabi. This language set contains translations of a video in which doctors talk about COVID-19 vaccination for children aged 5 to 11 and encourage parents and carers to book vaccinations for their children.
COVID-19 vaccination coverage in children
Due to the low uptake of vaccinations for children in the Canterbury-Bankstown, Bayside and George’s River LGAs, practice are strongly encouraged to promote childhood COVID-19 vaccination during the Easter school holidays. Download the AIR42A report to identify all children due for the COVID-19 vaccine or contact firstname.lastname@example.org for assistance with accessing the report for your practice.
Latest AusVaxSafety safety data shows most children report no side effects following Pfizer COVID-19 vaccination.
Flu vaccine safety data
With 2022 seasonal influenza vaccines now available across Australia, AusVaxSafety has commenced active surveillance to monitor the adverse event profile and safety of the vaccines in near-real time.
Help stop the flu in 2022
See the Dept of Health’s Help stop the flu in 2022 consumer campaign: This year, it’s even more important to get the influenza vaccine as we are more vulnerable to influenza. This is due to lower recent exposure to the virus and lower uptake of influenza vaccines in 2021. With international borders reopening, it’s likely we will see more influenza in 2022.
Annual vaccination is the most important measure to prevent influenza and its complications. The influenza vaccine is recommended for all individuals aged 6 months and over. See latest Influenza immunisation data – 1 March 2022 to 10 April 2022.
Who is eligible for a free NIP flu vaccine?
Annual influenza vaccination is funded under the National Immunisation Program (NIP) for people aged ≥6 months who are at increased risk of severe influenza. These include:
all Aboriginal and/or Torres Strait Islander people aged ≥6 months
all children aged 6 months to <5 years
all adults aged ≥65 years
people with specified medical conditions (refer to Table 1)
pregnant women (during any stage of pregnancy).
Prepare for flu season using CAT Plus
During the COVID-19 pandemic, there has been less exposure to the influenza virus and lower influenza vaccine coverage. A resurgence of influenza is expected in 2022 with borders reopening.
Send efficient and effective patient recalls in bulk directly through CAT to your patients for influenza vaccines. Find out more.
Webinar: Managing influenza and SARS-CoV-2 in winter 2022
Watch the NCIRS webinar recording of webinar to find out what you need to know to be prepared for influenza and COVID-19 vaccination in 2022.This webinar was recorded 5 April 2022, and chaired by Professor Kristine Macartney.
COVID-19 live stream update for GPs
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…